SRPT Annual Interest Expense
$22.01 M
-$31.24 M-58.67%
31 December 2023
Summary:
As of January 22, 2025, SRPT annual interest expense is $22.01 million, with the most recent change of -$31.24 million (-58.67%) on December 31, 2023. During the last 3 years, it has fallen by -$37.94 million (-63.28%). SRPT annual interest expense is now -65.35% below its all-time high of $63.52 million, reached on December 31, 2021.SRPT Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SRPT Quarterly Interest Expense
$4.92 M
+$86.00 K+1.78%
30 September 2024
Summary:
As of January 22, 2025, SRPT quarterly interest expense is $4.92 million, with the most recent change of +$86.00 thousand (+1.78%) on September 30, 2024. Over the past year, it has dropped by -$316.00 thousand (-6.04%). SRPT quarterly interest expense is now -73.74% below its all-time high of $18.73 million, reached on December 31, 2020.SRPT Quarterly Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SRPT TTM Interest Expense
$19.15 M
-$311.00 K-1.60%
30 September 2024
Summary:
As of January 22, 2025, SRPT TTM interest expense is $19.15 million, with the most recent change of -$311.00 thousand (-1.60%) on September 30, 2024. Over the past year, it has dropped by -$2.86 million (-12.99%). SRPT TTM interest expense is now -71.08% below its all-time high of $66.21 million, reached on September 30, 2021.SRPT TTM Interest Expense Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
SRPT Interest Expense Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -58.7% | -6.0% | -13.0% |
| 3 y3 years | -63.3% | -66.6% | -69.4% |
| 5 y5 years | -34.7% | -66.6% | -69.4% |
SRPT Interest Expense High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -65.3% | at low | -69.3% | +18.1% | -70.0% | at low |
| 5 y | 5-year | -65.3% | at low | -73.7% | +18.1% | -71.1% | at low |
| alltime | all time | -65.3% | +6298.3% | -73.7% | +1813.6% | -71.1% | +7351.4% |
Sarepta Therapeutics Interest Expense History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sept 2024 | - | $4.92 M(+1.8%) | $19.15 M(-1.6%) |
| June 2024 | - | $4.83 M(+16.0%) | $19.46 M(-2.0%) |
| Mar 2024 | - | $4.17 M(-20.4%) | $19.85 M(-9.8%) |
| Dec 2023 | $22.01 M(-58.7%) | $5.23 M(+0.1%) | $22.01 M(-6.2%) |
| Sept 2023 | - | $5.23 M(+0.1%) | $23.46 M(-28.8%) |
| June 2023 | - | $5.22 M(-17.4%) | $32.97 M(-24.7%) |
| Mar 2023 | - | $6.32 M(-5.5%) | $43.77 M(-17.8%) |
| Dec 2022 | $53.25 M(-16.2%) | $6.69 M(-54.6%) | $53.25 M(-15.0%) |
| Sept 2022 | - | $14.74 M(-8.1%) | $62.61 M(-2.0%) |
| June 2022 | - | $16.03 M(+1.5%) | $63.87 M(+0.3%) |
| Mar 2022 | - | $15.80 M(-1.6%) | $63.67 M(+0.2%) |
| Dec 2021 | $63.52 M(+6.0%) | $16.05 M(+0.3%) | $63.52 M(-4.1%) |
| Sept 2021 | - | $15.99 M(+1.0%) | $66.21 M(+3.3%) |
| June 2021 | - | $15.83 M(+1.2%) | $64.10 M(+3.4%) |
| Mar 2021 | - | $15.65 M(-16.4%) | $61.98 M(+3.4%) |
| Dec 2020 | $59.95 M | $18.73 M(+34.9%) | $59.95 M(+20.8%) |
| Sept 2020 | - | $13.89 M(+1.3%) | $49.61 M(+14.7%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| June 2020 | - | $13.71 M(+0.7%) | $43.24 M(+17.0%) |
| Mar 2020 | - | $13.62 M(+62.3%) | $36.95 M(+20.5%) |
| Dec 2019 | $30.67 M(-9.0%) | $8.39 M(+11.6%) | $30.67 M(+3.9%) |
| Sept 2019 | - | $7.52 M(+1.2%) | $29.53 M(-9.7%) |
| June 2019 | - | $7.43 M(+1.2%) | $32.69 M(-2.2%) |
| Mar 2019 | - | $7.33 M(+1.2%) | $33.41 M(-0.9%) |
| Dec 2018 | $33.71 M(+481.1%) | $7.25 M(-32.1%) | $33.71 M(+9.0%) |
| Sept 2018 | - | $10.68 M(+31.1%) | $30.94 M(+46.9%) |
| June 2018 | - | $8.14 M(+6.7%) | $21.06 M(+59.8%) |
| Mar 2018 | - | $7.63 M(+70.6%) | $13.18 M(+127.2%) |
| Dec 2017 | $5.80 M(+206.6%) | $4.48 M(+458.1%) | $5.80 M(+338.1%) |
| Sept 2017 | - | $802.00 K(+202.6%) | $1.32 M(+153.6%) |
| June 2017 | - | $265.00 K(+3.1%) | $522.00 K(+103.1%) |
| Mar 2017 | - | $257.00 K | $257.00 K |
| Dec 2016 | $1.89 M(+38.6%) | - | - |
| Dec 2015 | $1.36 M(+296.8%) | - | - |
| Dec 2008 | $344.00 K | - | - |
FAQ
- What is Sarepta Therapeutics annual interest expense?
- What is the all time high annual interest expense for Sarepta Therapeutics?
- What is Sarepta Therapeutics annual interest expense year-on-year change?
- What is Sarepta Therapeutics quarterly interest expense?
- What is the all time high quarterly interest expense for Sarepta Therapeutics?
- What is Sarepta Therapeutics quarterly interest expense year-on-year change?
- What is Sarepta Therapeutics TTM interest expense?
- What is the all time high TTM interest expense for Sarepta Therapeutics?
- What is Sarepta Therapeutics TTM interest expense year-on-year change?
What is Sarepta Therapeutics annual interest expense?
The current annual interest expense of SRPT is $22.01 M
What is the all time high annual interest expense for Sarepta Therapeutics?
Sarepta Therapeutics all-time high annual interest expense is $63.52 M
What is Sarepta Therapeutics annual interest expense year-on-year change?
Over the past year, SRPT annual interest expense has changed by -$31.24 M (-58.67%)
What is Sarepta Therapeutics quarterly interest expense?
The current quarterly interest expense of SRPT is $4.92 M
What is the all time high quarterly interest expense for Sarepta Therapeutics?
Sarepta Therapeutics all-time high quarterly interest expense is $18.73 M
What is Sarepta Therapeutics quarterly interest expense year-on-year change?
Over the past year, SRPT quarterly interest expense has changed by -$316.00 K (-6.04%)
What is Sarepta Therapeutics TTM interest expense?
The current TTM interest expense of SRPT is $19.15 M
What is the all time high TTM interest expense for Sarepta Therapeutics?
Sarepta Therapeutics all-time high TTM interest expense is $66.21 M
What is Sarepta Therapeutics TTM interest expense year-on-year change?
Over the past year, SRPT TTM interest expense has changed by -$2.86 M (-12.99%)